MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • MDS Virtual Congress 2020

    Painful Legs and Moving Toes (PLMT): A Case Series

    N. Labaure, I. Amorin, A. Lescano, G. Morando (Montevideo, Uruguay)

    Objective: Describe and characterize our PLMT patients in terms of clinical presentation, neurophysiology, imaging, associated conditions and response to treatment. Background: First described by Spillane…
  • MDS Virtual Congress 2020

    Ultrasound-guided treatment of action tremor of the upper limb with botulinum toxin

    M.C Costa, P. Pita-Lobo, C. Figueiredo, L. Rebordão, A. Cadete (Amadora, Portugal)

    Objective: To assess the functional benefit of ultrasound-guided treatment with botulinum toxin type A in patients with action tremor of the upper limb. Background: Action…
  • MDS Virtual Congress 2020

    Botulinum Toxin Injections for Upper Limb Dystonia with Tremor

    R. Rajan, R. Anandapadmanabhan, A. Saini, V.Y Venugopalan, A. Gupta, R. Bhatia, M. Singh, A. Srivastava, P. Srivastava (New Delhi, India)

    Objective: To study the effect of BoNT injections on tremor in patients with upper limb dystonia with hand tremor. Background: Tremor is a common accompaniment…
  • MDS Virtual Congress 2020

    Use of Botulinum Toxin: Experience in a Cohort of Essential Tremor Patients

    C. Shah, F. Jamal, A. Sarwar, G. Jackson (Houston, TX, USA)

    Objective: To review the treatment characteristics of botulinum toxin in medically refractory essential tremor (ET). Background: Treatment of medically refractory essential tremor has remained challenging…
  • 2019 International Congress

    Long-term safety and efficacy of rimabotulinumtoxinB in the treatment of adult sialorrhea

    K. Dashtipour, S. Isaacson, M. Lew, D. Chary, T. Clinch, R. Pahwa (Boca Raton, FL, USA)

    Objective: To assess the safety, tolerability and effectiveness of repeated rimabotulinumtoxinB injections in adults with troublesome sialorrhea over a period of 1 year. Background: Sialorrhea…
  • 2019 International Congress

    Describing Dystonia Phenomenology and Preliminary Treatment Response in Migraine Patients

    A. Yoo, S. Bobker, S. Broner, A. Lee, G. Auerbach, L. Klebanoff, M. Vo, H. Sarva (New York, NY, USA)

    Objective: To describe dystonia phenomenology and preliminary pain response to toxin therapy in a single-center migraine cohort. Background: The co-existence of headache and craniocervical dystonia…
  • 2019 International Congress

    RimbotulinumtoxinB in the treatment of adult sialorrhea

    S. Isaacson, W. Ondo, M. Lew, K. Dashtipour, D. Chary, T. Clinch, F. Pagan (Boca Raton, FL, USA)

    Objective: To assess efficacy, safety and tolerability of repeat injections of rimabotulinumtoxinBfor the treatment of sialorrhea. Background: Sialorrhea (drooling) can cause significant morbidity in several neurological disorders,…
  • 2019 International Congress

    Guided Self-rehabilitation Contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs in spastic hemiparesis: baseline data from the ENGAGE study

    J-M. Gracies, G. Francisco, R. Jech, S. Khatkova, C. Rios, P. Maisonobe (Créteil, France)

    Objective: To report baseline data from ENGAGE, an international phase 3b/4, prospective, single-arm, open-label study (NCT02969356) conducted in France, the Czech Republic, Russia and the USA.…
  • 2019 International Congress

    Duration of rimabotulinumtoxinB action in the treatment of adult sialorrhea

    S. Isaacson, M. Lew, F. Pagan, R. Pahwa, D. Chary, T. Clinch (Boca Raton, FL, USA)

    Objective: To assess the duration of rimabotulinumtoxinB action in the management of sialorrhea. Background: In neurological disorders, sialorrhea (drooling) is both prevalent and problematic. Local…
  • 2019 International Congress

    The effect of Guided Self-rehabilitation Contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs on voluntary movements in adults with spastic hemiparesis

    J-M. Gracies, G. Francisco, R. Jech, S. Khatkova, C. Rios, P. Maisonobe (Créteil, France)

    Objective: To report primary outcomes from ENGAGE, an international phase 3b/4, prospective, single-arm, open-label study (NCT02969356). Background: ENGAGE assessed effects of Guided Self-rehabilitation Contracts (GSC)…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 15
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley